WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2023> 39> 10

Volume: 39 Issue: 10

1. Further discussion on the antiviral treatment of chronic hepatitis B patients with indeterminate phase Page:2273—2276
2. Recognition of the clinical classification of acute-on-chronic liver failure: Redefinition from a new perspective of onset manifestations and dynamic outcomes Page:2277—2280
3. The definition and pathogenesis of acute-on-chronic liver failure Page:2281—2287
4. Evolution of the clinical scoring and classification system for acute-on-chronic liver failure Page:2288—2293
5. Development of acute-on-chronic liver failure in progressive chronic liver diseases: Risk prediction and stratified management Page:2294—2300
6. Prognostic evaluation of acute-on-chronic liver failure Page:2301—2306
7. Chinese expert consensus on clinical management of hepatopathy-related thrombocytopenia Page:2307—2320
8. An excerpt of EASL clinical practice guidelines on acute-on-chronic liver failure (2023) Page:2321—2327
9. An excerpt of EASL clinical practice guidelines on the management of liver diseases in pregnancy (2023) Page:2328—2335
10. Excerpt of an international multidisciplinary consensus statement on MAFLD and the risk of CVD (2023) Page:2336—2339
11. Mechanism of cytotoxic T lymphocyte-derived exosomes inhibiting hepatic stellate cell activation Page:2340—2347
12. Therapeutic effect of retention enema with compound rhubarb decoction on a rat model of minimal hepatic encephalopathy based on bile acid metabolomics Page:2348—2357
13. Clinical features of non-B, non-C hepatocellular carcinoma Page:2358—2365
14. Effect of synthetic peptide cSN50.1 on the malignant behavior of hepatocellular carcinoma HepG2 cells and its mechanism Page:2366—2374
15. Acute-on-chronic liver failure: Features and prognosis of a new clinical classification system based on onset manifestations Page:2375—2382
16. Value of peripheral blood lymphocyte count in evaluating the short-term prognosis of patients with acute-on-chronic liver failure Page:2383—2389
17. Clinical features of bacterial liver abscess in the context of coronavirus disease 2019 in Changchun, China Page:2390—2395
18. Expression and significance of response gene to complement 32 in liver regeneration after partial hepatectomy in mice Page:2396—2405
19. Efficacy and safety of 125I intraluminal irradiation combined with lenvatinib in treatment of progressive extrahepatic cholangiocarcinoma Page:2406—2412
20. Clinical effect of Qingre Lidan granules in preventing the recurrence of choledocholithiasis after laparoscopy combined with choledochoscopy Page:2413—2420
21. Efficacy of laparoscopic choledochoscopy combined with holmium laser lithotripsy versus traditional laparotomy in treatment of bile duct stones: A Meta-analysis Page:2421—2431
22. Establishment of a modified BISAP scoring system and its clinical significance in the early diagnosis and prognostic evaluation of severe acute pancreatitis Page:2432—2442
23. Role of heat shock protein 90 in hepatitis B virus replication Page:2443—2447
24. Research advances in hepatitis E virus infection in pregnancy Page:2448—2453
25. Research advances in the association between metabolic associated fatty liver and type 2 diabetes mellitus and the mechanism of comorbidity Page:2454—2459
26. Transjugular intrahepatic portosystemic shunt combined with collateral vessel embolization in treatment of gastroesophageal variceal bleeding in liver cirrhosis: Research advances and controversies Page:2460—2463
27. Recompensation of liver cirrhosis: Current status and challenges Page:2464—2469
28. Research advances in the role of blood metabolic markers in the treatment response and prognosis prediction of primary liver cancer Page:2470—2475
29. Research advances in natural drug and food monomers in prevention and treatment of alcoholic liver injury Page:2476—2484
30. Advances in the protective mechanism and clinical implications of autophagy in liver failure Page:2485—2490
31. Current research status of biliary stents Page:2491—2496
32. Research advances in hemorrhage after endoscopic retrograde cholangiopancreatography Page:2497—2505
33. Research advances in total pancreatectomy with autologous islet cell transplantation Page:2506—2512